Trust Signals Written by: FormBlends Medical Team, including contributors with backgrounds in pharmaceutical science and clinical research
Most importantly, numerous other neuroprotective and neurotrophic growth factors like BDNF-analogs and LM11A-31 are currently being studied for their cognitive and therapeutic benefits, especially their ability to preserve and promote neural networks and neuron health, particularly in the setting of neurodegenerative diseases like Alzheimer's disease, FrontoTemporal Dementia (FTD), Parkinson's Disease (PD), and Lewy-Body Disease, as well as ischemic or traumatic neural injury (68a) (68b) (68c) (68d)
For individual peptide safety profiles, see BPC-157 side effects and the GHK-Cu dosage guide
The IL-23/Th17 pathway inhibitors in the treatment of psoriasis and the risk of skin malignancies: a review
Browse our complete peptide catalog to find research-grade peptides for your laboratory needs
No finalized large-scale human clinical trials are published that demonstrate safety and efficacy in humans
